Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Consuming cholera toxin counteracts age-associated obesity.

Varian BJ, Poutahidis T, Haner G, Hardas A, Lau V, Erdman SE.

Oncotarget. 2019 Sep 17;10(53):5497-5509. doi: 10.18632/oncotarget.27137. eCollection 2019 Sep 17.

2.

Orthogonal Dietary Niche Enables Reversible Engraftment of a Gut Bacterial Commensal.

Kearney SM, Gibbons SM, Erdman SE, Alm EJ.

Cell Rep. 2018 Aug 14;24(7):1842-1851. doi: 10.1016/j.celrep.2018.07.032.

3.

Correction: Beneficial bacteria inhibit cachexia.

Varian BJ, Gourishetti S, Poutahidis T, Lakritz JR, Levkovich T, Kwok C, Teliousis K, Ibrahim YM, Mirabal S, Erdman SE.

Oncotarget. 2018 Jun 29;9(50):29536. doi: 10.18632/oncotarget.25750. eCollection 2018 Jun 29.

4.

Defining 'good health'.

Erdman SE.

Aging (Albany NY). 2016 Dec 29;8(12):3157-3158. doi: 10.18632/aging.101154. No abstract available.

5.

Gut microbiota modulate host immune cells in cancer development and growth.

Erdman SE, Poutahidis T.

Free Radic Biol Med. 2017 Apr;105:28-34. doi: 10.1016/j.freeradbiomed.2016.11.013. Epub 2016 Nov 10. Review.

6.

Microbial lysate upregulates host oxytocin.

Varian BJ, Poutahidis T, DiBenedictis BT, Levkovich T, Ibrahim Y, Didyk E, Shikhman L, Cheung HK, Hardas A, Ricciardi CE, Kolandaivelu K, Veenema AH, Alm EJ, Erdman SE.

Brain Behav Immun. 2017 Mar;61:36-49. doi: 10.1016/j.bbi.2016.11.002. Epub 2016 Nov 5.

7.

Microbes and Oxytocin: Benefits for Host Physiology and Behavior.

Erdman SE, Poutahidis T.

Int Rev Neurobiol. 2016;131:91-126. doi: 10.1016/bs.irn.2016.07.004. Epub 2016 Sep 13. Review.

PMID:
27793228
8.

Erratum to: Host lifestyle affects human microbiota on daily timescales.

David LA, Materna AC, Friedman J, Baptista MI, Blackburn MC, Perrotta A, Erdman SE, Alm EJ.

Genome Biol. 2016 May 31;17(1):117. No abstract available.

9.

Microbes and healthful longevity.

Erdman SE.

Aging (Albany NY). 2016 May;8(5):839-40. doi: 10.18632/aging.100969. No abstract available.

10.

Beneficial bacteria inhibit cachexia.

Varian BJ, Gourishetti S, Poutahidis T, Lakritz JR, Levkovich T, Kwok C, Teliousis K, Ibrahim YM, Mirabal S, Erdman SE.

Oncotarget. 2016 Mar 15;7(11):11803-16. doi: 10.18632/oncotarget.7730. Erratum in: Oncotarget. 2018 Jun 29;9(50):29536. Goureshetti, Sravya [corrected to Gourishetti, Sravya].

11.

Gut microbiota: Microbes offer engineering strategies to combat cancer.

Erdman SE.

Nat Rev Gastroenterol Hepatol. 2016 Mar;13(3):125-6. doi: 10.1038/nrgastro.2016.14. Epub 2016 Feb 10. No abstract available.

PMID:
26860267
12.

Commensal bacteria modulate the tumor microenvironment.

Poutahidis T, Erdman SE.

Cancer Lett. 2016 Sep 28;380(1):356-8. doi: 10.1016/j.canlet.2015.12.028. Epub 2015 Dec 29. Review.

13.

Old enemies meet new friends for colon cancer prevention.

Poutahidis T, Angelopoulou K, Erdman SE.

Oncoimmunology. 2015 Jun 1;4(10):e1027474. eCollection 2015 Oct.

14.

Gut bacteria and cancer.

Erdman SE, Poutahidis T.

Biochim Biophys Acta. 2015 Aug;1856(1):86-90. doi: 10.1016/j.bbcan.2015.05.007. Epub 2015 Jun 4. Review.

15.

Gut bacteria require neutrophils to promote mammary tumorigenesis.

Lakritz JR, Poutahidis T, Mirabal S, Varian BJ, Levkovich T, Ibrahim YM, Ward JM, Teng EC, Fisher B, Parry N, Lesage S, Alberg N, Gourishetti S, Fox JG, Ge Z, Erdman SE.

Oncotarget. 2015 Apr 20;6(11):9387-96.

16.

'Hygienic' lymphocytes convey increased cancer risk.

Levkovich T, Poutahidis T, Cappelle K, Smith MB, Perrotta A, Alm EJ, Erdman SE.

J Anal Oncol. 2014 Aug 12;3(3):113-121.

17.

Dietary microbes modulate transgenerational cancer risk.

Poutahidis T, Varian BJ, Levkovich T, Lakritz JR, Mirabal S, Kwok C, Ibrahim YM, Kearney SM, Chatzigiagkos A, Alm EJ, Erdman SE.

Cancer Res. 2015 Apr 1;75(7):1197-204. doi: 10.1158/0008-5472.CAN-14-2732. Epub 2015 Feb 25.

18.

Cholera-toxin suppresses carcinogenesis in a mouse model of inflammation-driven sporadic colon cancer.

Doulberis M, Angelopoulou K, Kaldrymidou E, Tsingotjidou A, Abas Z, Erdman SE, Poutahidis T.

Carcinogenesis. 2015 Feb;36(2):280-90. doi: 10.1093/carcin/bgu325. Epub 2014 Dec 30.

19.

Host lifestyle affects human microbiota on daily timescales.

David LA, Materna AC, Friedman J, Campos-Baptista MI, Blackburn MC, Perrotta A, Erdman SE, Alm EJ.

Genome Biol. 2014;15(7):R89. Erratum in: Genome Biol. 2016;17(1):117.

20.

The microbiome modulates the tumor macroenvironment.

Erdman SE, Poutahidis T.

Oncoimmunology. 2014 Mar 27;3:e28271. eCollection 2014.

21.

Urokinase-type plasminogen activator deficiency promotes neoplasmatogenesis in the colon of mice.

Karamanavi E, Angelopoulou K, Lavrentiadou S, Tsingotjidou A, Abas Z, Taitzoglou I, Vlemmas I, Erdman SE, Poutahidis T.

Transl Oncol. 2014 Apr;7(2):174-187.e5. doi: 10.1016/j.tranon.2014.02.002. Epub 2014 Mar 4.

22.

Gut microbiota and the paradox of cancer immunotherapy.

Poutahidis T, Kleinewietfeld M, Erdman SE.

Front Immunol. 2014 Apr 7;5:157. doi: 10.3389/fimmu.2014.00157. eCollection 2014. Review.

23.

Probiotic 'glow of health': it's more than skin deep.

Erdman SE, Poutahidis T.

Benef Microbes. 2014 Jun 1;5(2):109-19. doi: 10.3920/BM2013.0042. Review.

24.

Probiotic microbes sustain youthful serum testosterone levels and testicular size in aging mice.

Poutahidis T, Springer A, Levkovich T, Qi P, Varian BJ, Lakritz JR, Ibrahim YM, Chatzigiagkos A, Alm EJ, Erdman SE.

PLoS One. 2014 Jan 2;9(1):e84877. doi: 10.1371/journal.pone.0084877. eCollection 2014.

25.

Beneficial bacteria stimulate host immune cells to counteract dietary and genetic predisposition to mammary cancer in mice.

Lakritz JR, Poutahidis T, Levkovich T, Varian BJ, Ibrahim YM, Chatzigiagkos A, Mirabal S, Alm EJ, Erdman SE.

Int J Cancer. 2014 Aug 1;135(3):529-40. doi: 10.1002/ijc.28702. Epub 2014 Jan 10.

26.

Role of "Western diet" in inflammatory autoimmune diseases.

Manzel A, Muller DN, Hafler DA, Erdman SE, Linker RA, Kleinewietfeld M.

Curr Allergy Asthma Rep. 2014 Jan;14(1):404. doi: 10.1007/s11882-013-0404-6. Review.

27.

Microbial symbionts accelerate wound healing via the neuropeptide hormone oxytocin.

Poutahidis T, Kearney SM, Levkovich T, Qi P, Varian BJ, Lakritz JR, Ibrahim YM, Chatzigiagkos A, Alm EJ, Erdman SE.

PLoS One. 2013 Oct 30;8(10):e78898. doi: 10.1371/journal.pone.0078898. eCollection 2013.

28.

Pathogenic intestinal bacteria enhance prostate cancer development via systemic activation of immune cells in mice.

Poutahidis T, Cappelle K, Levkovich T, Lee CW, Doulberis M, Ge Z, Fox JG, Horwitz BH, Erdman SE.

PLoS One. 2013 Aug 26;8(8):e73933. doi: 10.1371/journal.pone.0073933. eCollection 2013.

29.

Microbial reprogramming inhibits Western diet-associated obesity.

Poutahidis T, Kleinewietfeld M, Smillie C, Levkovich T, Perrotta A, Bhela S, Varian BJ, Ibrahim YM, Lakritz JR, Kearney SM, Chatzigiagkos A, Hafler DA, Alm EJ, Erdman SE.

PLoS One. 2013 Jul 10;8(7):e68596. doi: 10.1371/journal.pone.0068596. Print 2013.

30.

Probiotic bacteria induce a 'glow of health'.

Levkovich T, Poutahidis T, Smillie C, Varian BJ, Ibrahim YM, Lakritz JR, Alm EJ, Erdman SE.

PLoS One. 2013;8(1):e53867. doi: 10.1371/journal.pone.0053867. Epub 2013 Jan 16.

31.

Castration eliminates conspecific aggression in group-housed CD1 male surveillance mice (Mus musculus).

Lofgren JL, Erdman SE, Hewes C, Wong C, King R, Chavarria TE, Discua AR, Fox JG, Maurer KJ.

J Am Assoc Lab Anim Sci. 2012;51(5):594-9.

32.

Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue.

Karagiannis GS, Poutahidis T, Erdman SE, Kirsch R, Riddell RH, Diamandis EP.

Mol Cancer Res. 2012 Nov;10(11):1403-18. doi: 10.1158/1541-7786.MCR-12-0307. Epub 2012 Sep 28. Review.

33.

New regulators of a high affinity Ca2+ influx system revealed through a genome-wide screen in yeast.

Martin DC, Kim H, Mackin NA, Maldonado-Báez L, Evangelista CC Jr, Beaudry VG, Dudgeon DD, Naiman DQ, Erdman SE, Cunningham KW.

J Biol Chem. 2011 Mar 25;286(12):10744-54. doi: 10.1074/jbc.M110.177451. Epub 2011 Jan 20.

34.

NF-κB1 inhibits TLR-induced IFN-β production in macrophages through TPL-2-dependent ERK activation.

Yang HT, Wang Y, Zhao X, Demissie E, Papoutsopoulou S, Mambole A, O'Garra A, Tomczak MF, Erdman SE, Fox JG, Ley SC, Horwitz BH.

J Immunol. 2011 Feb 15;186(4):1989-96. doi: 10.4049/jimmunol.1001003. Epub 2011 Jan 7.

35.

Helicobacter hepaticus infection in mice: models for understanding lower bowel inflammation and cancer.

Fox JG, Ge Z, Whary MT, Erdman SE, Horwitz BH.

Mucosal Immunol. 2011 Jan;4(1):22-30. doi: 10.1038/mi.2010.61. Epub 2010 Oct 13. Review.

36.

Cancer inflammation and regulatory T cells.

Erdman SE, Poutahidis T.

Int J Cancer. 2010 Aug 15;127(4):768-79. doi: 10.1002/ijc.25430. Review.

37.

Mutations in bone marrow-derived stromal stem cells unmask latent malignancy.

Houghton J, Li H, Fan X, Liu Y, Liu JH, Rao VP, Poutahidis T, Taylor CL, Jackson EA, Hewes C, Lyle S, Cerny A, Bowen G, Cerny J, Moore N, Kurt-Jones EA, Erdman SE.

Stem Cells Dev. 2010 Aug;19(8):1153-66. doi: 10.1089/scd.2009.0439.

38.

Roles for inflammation and regulatory T cells in colon cancer.

Erdman SE, Poutahidis T.

Toxicol Pathol. 2010 Jan;38(1):76-87. doi: 10.1177/0192623309354110. Epub 2009 Dec 17. Review.

39.

Unifying roles for regulatory T cells and inflammation in cancer.

Erdman SE, Rao VP, Olipitz W, Taylor CL, Jackson EA, Levkovich T, Lee CW, Horwitz BH, Fox JG, Ge Z, Poutahidis T.

Int J Cancer. 2010 Apr 1;126(7):1651-65. doi: 10.1002/ijc.24923.

40.

CD4+ lymphocytes modulate prostate cancer progression in mice.

Poutahidis T, Rao VP, Olipitz W, Taylor CL, Jackson EA, Levkovich T, Lee CW, Fox JG, Ge Z, Erdman SE.

Int J Cancer. 2009 Aug 15;125(4):868-78. doi: 10.1002/ijc.24452.

41.

Conserved WCPL and CX4C domains mediate several mating adhesin interactions in Saccharomyces cerevisiae.

Huang G, Dougherty SD, Erdman SE.

Genetics. 2009 May;182(1):173-89. doi: 10.1534/genetics.108.100073. Epub 2009 Mar 18.

42.

Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice.

Erdman SE, Rao VP, Poutahidis T, Rogers AB, Taylor CL, Jackson EA, Ge Z, Lee CW, Schauer DB, Wogan GN, Tannenbaum SR, Fox JG.

Proc Natl Acad Sci U S A. 2009 Jan 27;106(4):1027-32. doi: 10.1073/pnas.0812347106. Epub 2009 Jan 21.

43.

Cytotoxic-T-lymphocyte-associated antigen 4 blockade abrogates protection by regulatory T cells in a mouse model of microbially induced innate immune-driven colitis.

Watanabe K, Rao VP, Poutahidis T, Rickman BH, Ohtani M, Xu S, Rogers AB, Ge Z, Horwitz BH, Fujioka T, Erdman SE, Fox JG.

Infect Immun. 2008 Dec;76(12):5834-42. doi: 10.1128/IAI.00542-08. Epub 2008 Sep 29.

44.

c-Rel is essential for the development of innate and T cell-induced colitis.

Wang Y, Rickman BH, Poutahidis T, Schlieper K, Jackson EA, Erdman SE, Fox JG, Horwitz BH.

J Immunol. 2008 Jun 15;180(12):8118-25.

45.

Mast cells are an essential hematopoietic component for polyp development.

Gounaris E, Erdman SE, Restaino C, Gurish MF, Friend DS, Gounari F, Lee DM, Zhang G, Glickman JN, Shin K, Rao VP, Poutahidis T, Weissleder R, McNagny KM, Khazaie K.

Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19977-82. Epub 2007 Dec 6.

46.

Rapid reversal of interleukin-6-dependent epithelial invasion in a mouse model of microbially induced colon carcinoma.

Poutahidis T, Haigis KM, Rao VP, Nambiar PR, Taylor CL, Ge Z, Watanabe K, Davidson A, Horwitz BH, Fox JG, Erdman SE.

Carcinogenesis. 2007 Dec;28(12):2614-23. Epub 2007 Aug 27.

PMID:
17724375
47.
48.

Breast cancer: should gastrointestinal bacteria be on our radar screen?

Rao VP, Poutahidis T, Fox JG, Erdman SE.

Cancer Res. 2007 Feb 1;67(3):847-50. Review. Erratum in: Cancer Res. 2007 Mar 15;67(6):2904.

49.

Inhibition of Helicobacter hepaticus-induced colitis by IL-10 requires the p50/p105 subunit of NF-kappa B.

Tomczak MF, Erdman SE, Davidson A, Wang YY, Nambiar PR, Rogers AB, Rickman B, Luchetti D, Fox JG, Horwitz BH.

J Immunol. 2006 Nov 15;177(10):7332-9.

50.

Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice.

Rao VP, Poutahidis T, Ge Z, Nambiar PR, Boussahmain C, Wang YY, Horwitz BH, Fox JG, Erdman SE.

Cancer Res. 2006 Aug 1;66(15):7395-400.

Supplemental Content

Loading ...
Support Center